BETHLEHEM, Pa., March 01, 2018 -- B. Braun Medical Inc. will showcase its innovative technology portfolio at the Healthcare Information and Management Systems Society (HIMSS) Annual Conference and Exhibition, March 5 – 8 in Las Vegas.
During this year’s HIMSS Interoperability Showcase™ tour, attendees will have an opportunity to observe B. Braun participating in a Cardiovascular & Diabetes Risk Use Case scenario, demonstrating its integration capabilities with Epic, Spōk, GuardRFID, Philips and Omnicell.
“We look forward to the opportunity to interact with other healthcare professionals at HIMSS to demonstrate how our latest technologies are used in the same kind of clinical scenarios our customers face every day,” said Tom Sutton, Vice President of Marketing, Medical Device and Pharmaceutical Systems at B. Braun Medical. “We are deeply committed to improving patient and clinician safety, and enhancing healthcare outcomes.”
Additionally, at its booth #13054, B. Braun will showcase the benefits of its Infusomat® Space Infusion Pump when wirelessly integrated with a healthcare provider’s EMR system by demonstrating its AutoCOMPLETE™ Integrated EMR functions. AutoCOMPLETE includes AutoProgramming, AutoDocumentation and AutoNotification – the highest level of integration on B. Braun’s Synchronized Intelligence™ Infusion Platform and the first, wireless integrated technology system for IV pump infusion that is IHE certified for all three AutoCOMPLETE integration functions. The company also will demonstrate real-time infusion insight available with its DoseTrac® Infusion Management Software, a complimentary tool for continuous quality improvement, drug library, and AutoProgramming compliance tracking.
In addition to AutoCOMPLETE interoperability, integration is available with real-time location system (RTLS) and alarm management systems. STANLEY Healthcare, (booth #2243), will be discussing integration between B. Braun’s Infusomat pump and their RTLS MobileView application.
To further underscore the utility of a similar type of interoperability technology, McLaren Flint Hospital, a pump customer of B. Braun Medical, will give a presentation titled, Real ROI: Using RTLS to Improve Pump Utilization and Save $1M. The presentation will take place on Tuesday, March 6, from 4 - 5 p.m., at Galileo 901*.
B. Braun’s Infusomat pump is the first step to a wireless, integrated technology system that can help clinicians achieve 100% drug library compliance, minimize medication errors and reduce alarms and alerts. Its compact and intuitive design allows for flexibility and easy transport within a healthcare facility, promoting efficiencies in hospital or outpatient settings.
*Verify location in HIMSS session catalog in the event of room change.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. Other key product areas include ostomy and wound care, dialysis, nutrition, pharmacy admixture and compounding. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 61,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
Contact:
Jason Ford
B. Braun Medical Inc.
610.997.4722
[email protected]


Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 



